As filed with the Securities and Exchange Commission on August 31, 2017
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number 811-22394
CHOU AMERICA MUTUAL FUNDS
Three Canal Plaza, Suite 600
Portland, Maine 04101
Michael J. McKeen, Principal Financial Officer
Three Canal Plaza, Suite 600
Portland, Maine 04101
207-347-2000
Date of fiscal year end: December 31
Date of reporting period: January 1, 2017 – June 30, 2017
ITEM 1. REPORT TO STOCKHOLDERS.
CHOU AMERICA MUTUAL FUNDS
Semi Annual Report
June 30, 2017
(Unaudited)
Fund Adviser:
Chou America Management Inc.
110 Sheppard Ave. East
Suite 301, Box 18
Toronto, Ontario, Canada M2N 6Y8
Toll Free: (877) 755-5188
TABLE OF CONTENTS |
A Message to our Shareholders | 1 |
Schedules of Investments | 10 |
Statements of Assets and Liabilities | 16 |
Statements of Operations | 17 |
Statements of Changes | 18 |
Financial Highlights | 19 |
Notes to Financial Statements | 21 |
Additional Information | 27 |
CHOU OPPORTUNITY FUND A MESSAGE TO OUR SHAREHOLDERS JUNE 30, 2017 |
Dear Shareholder,
For the six months ending June 30, 2017, the Chou Opportunity Fund (the "Fund") was up 1.38%, while the S&P 500 Total Return Index generated a return of 9.34% during the same period. The Fund's prior performance is not necessarily indicative of how the Fund will perform in the future.
Portfolio Commentary
In the first half of the year, the main positive contributors to the Fund's performance included the Bank of America and JPMorgan Chase TARP warrants, as well as UTStarcom Holdings and Valeant Pharmaceuticals.
The equity security holdings of Sears Hometown and Outlet Stores, Chicago Bridge & Iron, Resolute Forest Products, and MBIA Inc. contributed negatively to the Fund's performance in the first six months of 2017.
During the period, the Fund initiated a position in Teva Pharmaceutical Industries, Endo International, and wrote call options on Resolute Forest Products expiring on October 20, 2017 and Valeant Pharmaceuticals expiring on January 18, 2019.
The Fund also reduced holdings of Bank of America, JPMorgan and General Motors TARP warrants, as well as Sears Holdings during the first half of 2017.
U.S. Bank TARP Warrants
Overall, investments in the TARP warrants of Bank of America, Wells Fargo and JPMorgan Chase performed well in 2017, as reflected by the increases in prices of each position shown in the following table.
Warrants | Price as of Dec. 31, 2016 | Price as of June 30, 2017 | Percentage Change |
Bank of America (Jan. 16, 2019) | $9.95 | $12.04 | 21.01% |
Wells Fargo (Oct. 28, 2018) | $21.33 | $22.20 | 4.08% |
JPMorgan Chase (Oct. 28, 2018) | $44.27 | $50.29 | 13.60% |
The maturity date for the TARP warrants is now less than two years away. As the time element gets shorter, we believe that the warrant is likely to become more speculative by nature and therefore we have started to reduce or eliminate the positions in the various TARP warrants. If we believe that the banks in question may still be undervalued, then we would be more likely to invest in the common stock of the banks.
However, it is important to note that any future decision to sell the TARP warrants or buy the common stock will be based on our view of the markets at the time, as well as the issuers that exist when we make any such investment decision.
EXCO Resources
As of June 30, 2017, the Fund owned about $19 million worth of EXCO Resources (EXCO)'s 1.75 lien term loan (converted from the second-lien term loan held previously in Feb. 2017), with $26 million in par value. This is the largest position in the portfolio, comprising more than 20% of the assets of the Fund (at market value).
We liked this security because it met our criteria for investing in the oil and gas sector. The criteria that we considered in analyzing this type of investment is that the security should be:
1. A very senior term loan or note;
1 |
CHOU OPPORTUNITY FUND A MESSAGE TO OUR SHAREHOLDERS JUNE 30, 2017 |
2. Issued by a company with a significantly limited ability to add senior or pari-passu debt to its capital structure; and
3. Of a type that if the company restructures or goes into bankruptcy, the recovery value of the bond is likely to be greater than the current price of the bond.
In addition to the security being very senior in the capital structure, we also hold the view that management seems to be making good decisions with respect to the allocation of capital in a tough environment.
Valeant and the Pharmaceutical Industry
As if Valeant has not given enough pain and anguish to our shareholders, we believe pharmaceutical stocks as a group are selling at attractive valuations. They generate their earnings in cash and most of them are selling at less than 10 times earnings. Some of them are down more than 50% from their highs, which is what caught our attention initially. It may look like we are adding more emotional fuel to the fire from our experience with Valeant but we look at mispriced stocks on a case-by-case basis. Given our current favorable view of the pharmaceutical industry generally, as next discussed in greater detail, we expect to invest in stocks of more than two or more pharmaceutical companies (that is, to utilize a so-called "basket approach"), in order to reduce the potential adverse effect on fund returns that could result from Food and Drug Administration (FDA) approval and patent expiration issues faced by a single company.
A Historical Perspective
What the pharmaceutical industry has been going through lately reminds me of what happened in the U.S. in 1994. A year earlier, then-president Bill Clinton appointed his wife, Hillary, to head a committee to prepare legislation for overhauling the U.S. health-care system, sending ripples of fear among investors of pharmaceutical stocks. It appeared as if drug prices would be set by the government on the basis of what it would cost to manufacture the product rather than being set by the market. Almost all pharmaceuticals stocks dived for the next of couple of years to unreasonable bargain levels.
It started with the 1992 U.S. presidential election. Clinton, the Democratic president-elect at the time vowed to make drug-price containment and universal health-care a cornerstone of his administration's plan to cut the nation's health-care bill, and promised to unveil a sweeping reform plan within his first 100 days in office. Several other politicians also joined the assault on the pharmaceutical industry by criticizing manufacturers for "drug price gouging" on critical medicines that patients needed by raising prices as high as three times the inflation rate in the 1980s. The political message was to protect American consumers from unfair and unaffordable drug prices by taking away the industry's carrots and replacing them with sticks.
As nervous investors feared that the incoming administration would enforce a tough pricing policy for prescription drugs, drug stocks were hammered starting in the pre-inaugural weeks, and continued to deteriorate with Clinton's victory in November 1992 and throughout debates over Clinton's health-care reform proposal from 1993 to 1994 (see Figure 1). The market psychology toward pharmaceutical stocks hit a decade low, as concerns heightened over the drug firms' ability to maintain their profit margins in a constrained pricing environment, despite new products in the pipeline.
Some of the key drug-related legislation proposed then as part of the health-care reform included:
· | A new National Health Board would determine the "reasonableness" of new drug prices based on prices charged in other countries and producer costs. They would investigate "unreasonable" drug prices, and |
2 |
CHOU OPPORTUNITY FUND A MESSAGE TO OUR SHAREHOLDERS JUNE 30, 2017 |
require companies to bring prices in parity with other nations if a drug price was higher in the U.S. than abroad. |
· | Drug companies would have to return to Medicare a rebate of 15% of their average nationwide price of each drug paid for by Medicare. |
· | The Secretary of Health and Human Services could bargain down the prices of new drugs before Medicare agreed to pay for them. Failures to negotiate an acceptable price could lead to total exclusion from Medicare coverage. |
· | Doctors would need permission from a government official to prescribe what were deemed as unreasonably priced drugs for Medicare patients. |
The health-care reform package was eventually defeated in August 1994, sending an air of relief to the pharmaceutical stocks. They returned to their more fairly valued levels set from 1994 to 1998 (see Figure 2). The Republican revolution led by Newt Gingrich gave Republicans control of the Senate and House of Representatives, putting the final nail in the coffin for a health-care overhaul under the Clinton administration.
Similar political rhetoric returned in the latest U.S. election, when both Donald Trump and Hillary Clinton called out drug companies for outrageous and unjustified pricing practices. However, the historical and economic challenges faced in the 1990s still exist today, providing realistic limits to what politicians can do to manage drug prices.
Below are the graphs that compare the prices of three pharmaceutical stock prices both before and after August 1994.
FIGURE 1.
CHOU OPPORTUNITY FUND SCHEDULE OF INVESTMENTS JUNE 30, 2017 |
Equity Securities - 48.3% |
Common Stock - 48.3% |
Shares | Security Description | Value |
Communications - 2.3% | |||||||
15,000 | Overstock.com, Inc. (a) | $ | 244,500 | ||||
645,181 | UTStarcom Holdings Corp. (a) | 1,509,723 | |||||
1,754,223 | |||||||
Consumer Discretionary - 5.6% | |||||||
37,904 | Sears Canada, Inc. (a) | 30,399 | |||||
426,608 | Sears Holdings Corp. (a)(b) | 3,779,747 | |||||
197,013 | Sears Hometown and Outlet Stores, Inc. (a)(b) | 531,935 | |||||
4,342,081 | |||||||
Consumer Staples - 22.4% | |||||||
211,319 | Ascent Capital Group, Inc., Class A (a) | 3,245,860 | |||||
295,000 | Endo International PLC (a) | 3,295,150 | |||||
95,000 | Teva Pharmaceutical Industries, Ltd., ADR | 3,155,900 | |||||
441,000 | Valeant Pharmaceuticals International, Inc. (a)(b)(c) | 7,629,300 | |||||
17,326,210 | |||||||
Energy - 0.4% | |||||||
99,228 | EXCO Resources, Inc. (a) | 262,954 | |||||
Financials - 2.8% | |||||||
225,000 | MBIA, Inc. (a)(b) | 2,121,750 | |||||
Industrials - 2.4% | |||||||
95,000 | Chicago Bridge & Iron Co. NV (b) | 1,874,350 | |||||
Materials - 12.4% | |||||||
2,179,359 | Resolute Forest Products, Inc. (a)(c) | 9,589,180 | |||||
Total Common Stock (Cost $73,434,790) | 37,270,748 |
Warrants - 15.4% |
Shares | Security Description | Exer. Price | Exp. Date | Value | |||||||
272,430 | Bank of America Corp. (a) | $12.90 | 01/16/19 | 3,280,057 | |||||||
194,832 | General Motors Co. (a) | 18.33 | 07/10/19 | 3,376,439 | |||||||
70,000 | JPMorgan Chase & Co. (a) | 42.03 | 10/28/18 | 3,520,300 | |||||||
77,400 | Wells Fargo & Co. (a) | 34.01 | 10/28/18 | 1,718,280 |
Total Warrants (Cost $4,594,255) | 11,895,076 |
Preferred Stock - 0.0% | ||||||||||
Communications - 0.0% | ||||||||||
Rate | ||||||||||
1,500 | Overstock.com, Inc. | 1.00 | % | 24,262 | ||||||
Total Preferred Stock (Cost $23,520) | 24,262 |
Total Equity Securities (Cost $78,052,565) | 49,190,086 |
Fixed Income Securities - 24.0% |
Syndicated Loan - 24.0% |
Principal | Security Description | Rate | Maturity | Value |
$ | 26,000,000 | Exco Resources | 15.00 | % | 10/26/20 | 18,590,000 | |||||
Total Fixed Income Securities (Cost $19,694,399) | 18,590,000 |
Collateral Received for Securities Loaned (d) - 0.7% |
Principal | Security Description | Rate | Maturity | Value | |||||||
$ | 161,122 | U.S. Treasury Bills | 0.00 | % | 07/13/17- 12/21/17 | $ | 160,410 | ||||
89,723 | U.S. Treasury Bonds | 2.88- 7.63 | 02/15/25- 02/15/47 | 92,796 | |||||||
1 | U.S. Treasury Bond Coupon Strip | 0.00 | 11/15/25 | 1 | |||||||
204,231 | U.S. Treasury Notes | 0.63- 3.63 | 07/31/17- 02/15/27 | 203,458 | |||||||
65,711 | U.S. Treasury Inflation Indexed Notes | 0.13- 3.38 | 04/15/18- 02/15/46 | 69,848 | |||||||
Total Collateral Received for Securities Loaned (Cost $526,513) | 526,513 |
Total Investments in Securities- 88.4% (Cost $98,273,477)* | 68,306,599 |
Written Options- (1.4)% |
Call Options Written-(1.4)% |
Shares | Security Description | Strike Price | Exp. Date | Value | |||||||
(4,618 | ) | Resolute Forest Products | $10.00 | 10/20/17 | (46,180 | ) | |||||
(4,000 | ) | Valeant Pharmaceuticals International, Inc. | 27.50 | 01/18/19 | (1,020,000 | ) |
Total Written Options (Premiums Received $1,074,952)* | (1,066,180 | ) |
Other Assets & Liabilities, Net – 13.0% | 10,031,562 | ||
Net Assets – 100.0% | $ | 77,271,981 |
ADR | American Depositary Receipt |
PLC | Public Limited Company |
(a) | Non-income producing security. |
(b) | This security or a portion of the security is out on loan as of June 30, 2017, and may be collateralized by cash not reflected on this Schedule of Investments. Total loaned securities had a value of $7,545,435. |
(c) | Subject to call option written by the Fund. |
(d) | These securities represent the collateral received in connection with securities out on loan as of June 30, 2017. |
* Cost for federal income tax purposes is substantially the same as for financial statement purposes and net unrealized depreciation consists of:
Gross Unrealized Appreciation | $ | 8,532,135 | ||
Gross Unrealized Depreciation | (38,490,241 | ) | ||
Net Unrealized Depreciation | $ | (29,958,106 | ) |
See Notes to Financial Statements. | 11 |
CHOU OPPORTUNITY FUND SCHEDULE OF INVESTMENTS JUNE 30, 2017 |
The inputs or methodology used for valuing securities are not necessarily an indication of the risks associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Security Valuation section in Note 2 of the accompanying Notes to Financial Statements.
The following is a summary of the inputs used to value the Fund's investments and other financial instruments and liabilities as of June 30, 2017.
Level 1 | Level 2 | Level 3 | Total |
Assets | ||||||||||||||||
Investments At Value | ||||||||||||||||
Common Stock | $ | 37,270,748 | $ | - | $ | - | $ | 37,270,748 | ||||||||
Warrants | 11,895,076 | - | - | 11,895,076 | ||||||||||||
Preferred Stock | - | 24,262 | - | 24,262 | ||||||||||||
Syndicated Loan | - | 18,590,000 | - | 18,590,000 | ||||||||||||
Collateral Received for Securities Loaned | - | 526,513 | - | 526,513 | ||||||||||||
Total Investments At Value | $ | 49,165,824 | $ | 19,140,775 | $ | - | $ | 68,306,599 |
Total Assets | $ | 49,165,824 | $ | 19,140,775 | $ | - | $ | 68,306,599 |
Liabilities | ||||||||||||||||
Other Financial Instruments** | ||||||||||||||||
Written Options | $ | (1,066,180 | ) | $ | - | $ | - | $ | (1,066,180 | ) |
Total Liabilities | $ | (1,066,180 | ) | $ | - | $ | - | $ | (1,066,180 | ) |
**Other Financial Instruments are derivative instruments not reflected in the Total Investments in Securities, such as written options, which are valued at their market value at period end.
The Fund utilizes the end of period methodology when determining transfers. There were no transfers among Level 1, Level 2 and Level 3 for the period ended June 30, 2017.
PORTFOLIO HOLDINGS | ||
% of Net Assets | ||
Communications | 2.3 | % |
Consumer Discretionary | 5.6 | % |
Consumer Staples | 22.4 | % |
Energy | 0.4 | % |
Financials | 2.8 | % |
Industrials | 2.4 | % |
Materials | 12.4 | % |
Warrants | 15.4 | % |
Syndicated Loan | 24.0 | % |
Collateral Received for Securities Loaned | 0.7 | % |
Written Options | (1.4) | % |
Other Assets and Liabilities, Net (1) | 13.0 | % |
Total | 100.0 | % |
(1) "Other Assets and Liabilites, Net" consists of assets, other than derivatives and securities, less liabilities and includes uninvested cash which represented 12.6% of the Fund's total net assets at June 30, 2017. For more information, see the Fund's Statement of Assets and Liabilities.
Equity Securities - 16.6% |
Common Stock - 10.9% |
Shares | SecurityDescription | Value |
Consumer Discretionary - 6.8% | |||||||
788,273 | Wow Unlimited Media, Inc., Class A (a) | $ | 1,215,720 | ||||
Energy - 4.1% | ||||||||
2,452 | Contura Energy, Inc. (a) | 160,606 | ||||||
12,065 | EXCO Resources, Inc. (a) | 31,972 | ||||||
31,249 | SandRidge Energy, Inc. (a) | 537,795 | ||||||
730,373 |
Total Common Stock(Cost $1,954,391) | 1,946,093 |
Preferred Stock - 5.7% |
Rate |
Financials - 4.4% | |||||||||
50,765 | Sears Roebuck Acceptance Corp. | 7.00 | % | 457,520 | |||||
36,107 | Sears Roebuck Acceptance Corp. | 7.40 | 325,414 | ||||||
782,934 | |||||||||
Materials - 1.3% | |||||||||
639,000 | Centrus Energy Corp. (b) | 7.50 | 233,235 | ||||||
Total Preferred Stock(Cost $1,104,795) | 1,016,169 |
Warrants - 0.0% |
Shares | Security Description | Exer. Price | Exp. Date | |||||||
2,167 | Dex Media - Warrant (a) | $ | 13.55 | 08/15/23 | 217 |
Total Warrants (Cost $0) | 217 |
Total Equity Securities (Cost $3,059,186) | 2,962,479 |
Fixed Income Securities - 57.5% |
Corporate Convertible Bonds - 15.9% |
Principal | Security Description | Rate | Maturity | Value |
Consumer Staples - 13.5% | |||||||||||
$ | 3,000,000 | Ascent Capital Group, Inc. | 4.00 | % | 07/15/20 | 2,405,625 | |||||
Financials - 2.4% | |||||||||||
850,000 | Atlanticus Holdings Corp. | 5.88 | 11/30/35 | 418,625 | |||||||
Total Corporate Convertible Bonds (Cost $3,129,603) | 2,824,250 |
Corporate Non-Convertible Bonds - 28.7% |
Consumer Discretionary - 4.4% | |||||||||||
800,000 | International Automotive Components Group SA (b) | 9.13 | 06/01/18 | 781,000 | |||||||
Consumer Staples - 12.2% | ||||||||||
800,000 | Avangardco Investments Public, Ltd. (d) | 10.00 | 10/29/18 | 190,160 |
1,000,000 | Mriya Agro Holding PLC (c) | 9.45 | 04/19/18 | 65,000 | ||||||
5,101,866 | Ukrlandfarming PLC (c) | 10.88 | 03/26/18 | 1,225,468 | ||||||
800,000 | Valeant Pharmaceuticals International, Inc. (b)(e) | 6.13 | 04/15/25 | 680,000 |
Principal | Security Description | Rate | Maturity | Value |
Energy - 5.6% | ||||||||||
$ | 189,000 | EXCO Resources, Inc. | 8.50 | % | 04/15/22 | $ | 119,070 | |||
1,000,000 | Westmoreland Coal Co. (b) | 8.75 | 01/01/22 | 885,000 | ||||||
1,004,070 | ||||||||||
Materials - 6.5% | ||||||||||
453,617 | Centrus Energy Corp. (b) | 8.25 | 02/28/27 | 367,430 | ||||||
800,000 | Resolute Forest Products, Inc. (e) | 5.88 | 05/15/23 | 783,000 | ||||||
225,000 | Sino-Forest Corp. (d) | 6.25 | 10/21/17 | 844 | ||||||
400,000 | Sino-Forest Corp. (d) | 6.25 | 10/21/17 | 1,500 | ||||||
1,152,774 |
Total Corporate Non-Convertible Bonds (Cost $9,569,817) | 5,098,472 |
Syndicated Loans - 12.9% |
Principal | Security Description | Rate | Maturity | Value |
152,383 | Dex Media, Inc. | 11.23 | 07/29/21 | 155,621 | ||||||
3,000,000 | EXCO Resources, Inc. (f) | 15.00 | 10/26/20 | 2,145,000 |
Total Syndicated Loans (Cost $2,640,809) | 2,300,621 |
Total Fixed Income Securities (Cost $15,340,229) | 10,223,343 | |||
Total Investments - 74.1% (Cost $18,399,415)* | $ | 13,185,822 |
Other Assets & Liabilities, Net – 25.9% | 4,604,678 |
Net Assets – 100.0% | $ | 17,790,500 |
PLC | Public Limited Company |
(a) | Non-income producing security. |
(b) | Security exempt from registration under Rule 144A under the Securities Act of 1933. At the period end, the value of these securities amounted to $2,946,665 or 16.6% of net assets. |
(c) | Security is currently in default. |
(d) | Security represents entitlement to potential distributions from a litigation trust. |
(e) | This security or a portion of the security is out on loan as of June 30, 2017 and is collateralized by cash not reflected on this Schedule of Investments. Total loaned securities had a value of $1,353,248 as of June 30, 2017. |
(f) | Payment in Kind Security. Security that gives the issuer the option at each interest payment date of making interest payments in either cash or additional debt securities. |
* Cost for federal income tax purposes is substantially the same as for financial statement purposes and net unrealized depreciation consists of:
Gross Unrealized Appreciation | $ | 671,800 | ||
Gross Unrealized Depreciation | (5,885,393 | ) | ||
Net Unrealized Depreciation | $ | (5,213,593 | ) |
The inputs or methodology used for valuing securities are not necessarily an indication of the risks associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used in the table below, please refer to the Security Valuation section in Note 2 of the accompanying Notes to Financial Statements.
The following is a summary of the inputs used to value the Fund's investments and other financial instruments and liabilities as of June 30, 2017.
Level 1 | Level 2 | Level 3 | Total |
Assets | ||||||||||||||||
Investments At Value | ||||||||||||||||
Common Stock | $ | 1,946,093 | $ | - | $ | - | $ | 1,946,093 | ||||||||
Preferred Stock | - | 1,016,169 | - | 1,016,169 | ||||||||||||
Warrants | 217 | - | - | 217 | ||||||||||||
Corporate Convertible Bonds | - | 2,824,250 | - | 2,824,250 | ||||||||||||
Corporate Non-Convertible Bonds | - | 5,098,472 | - | 5,098,472 | ||||||||||||
Syndicated Loans | - | 2,300,621 | - | 2,300,621 | ||||||||||||
Total Assets | $ | 1,946,310 | $ | 11,239,512 | $ | - | $ | 13,185,822 |
The Fund utilizes the end of period methodology when determining transfers. There were no transfers among Level 1, Level 2 and Level 3 for the period ended June 30, 2017.
PORTFOLIO HOLDINGS |
% of Net Assets | ||
Consumer Discretionary | 11.2 | % |
Consumer Staples | 25.7 | % |
Energy | 9.7 | % |
Financials | 6.8 | % |
Materials | 7.8 | % |
Syndicated Loans | 12.9 | % |
Warrants | 0.0 | % |
Other Assets & Liabilities, Net (1) | 25.9 | % |
100.0 | % |
(1) "Other Assets & Liabilites, Net" consists of assets, other than derivatives and securities, less liabilities and includes uninvested cash which represented 22.3% of the Fund's total net assets at June 30, 2017. For more information, see the Fund's Statement of Assets and Liabilities.
120 | CHOU OPPORTUNITY FUND | CHOU INCOME FUND | ||||||||
ASSETS | ||||||||||
. | Total investments, at value (including collateral received on securities loaned (Cost $98,273,477 and $18,399,415, respectively)) | $ | 68,306,599 | $ | 13,185,822 | |||||
Cash | 9,735,422 | 3,964,175 | ||||||||
Foreign currency (Cost $0 and $346,058, respectively) | - | 357,279 | ||||||||
Receivables: | ||||||||||
Investment securities sold | 553,947 | 93,539 | ||||||||
Dividends and interest | 284,353 | 198,732 | ||||||||
Prepaid expenses | 17,885 | 17,155 | ||||||||
Total Assets | 78,898,206 | 17,816,702 | ||||||||
LIABILITIES | ||||||||||
Call options written, at value (Premiums received $1,074,952 and $0, respectively) | 1,066,180 | - | ||||||||
Payable for collateral received on securities loaned | 526,513 | - | ||||||||
Accrued Liabilities: | ||||||||||
Investment adviser fees | - | 3,378 | ||||||||
Trustees' fees and expenses | 5 | 16 | ||||||||
Fund services fees | 6,539 | 6,787 | ||||||||
Other expenses | 26,988 | 16,021 | ||||||||
Total Liabilities | 1,626,225 | 26,202 | ||||||||
NET ASSETS | $ | 77,271,981 | $ | 17,790,500 | ||||||
COMPONENTS OF NET ASSETS | ||||||||||
Paid-in capital | $ | 102,998,519 | $ | 23,354,037 | ||||||
Undistributed (distributions in excess of) net investment income | 25,917 | (478,633 | ) | |||||||
Accumulated net realized gain | 4,205,651 | 117,468 | ||||||||
Net unrealized depreciation | (29,958,106 | ) | (5,202,372 | ) | ||||||
NET ASSETS | $ | 77,271,981 | $ | 17,790,500 | ||||||
SHARES OF BENEFICIAL INTEREST AT NO PAR VALUE (UNLIMITED SHARES AUTHORIZED) | 8,530,066 | 2,219,151 | ||||||||
NET ASSET VALUE, OFFERING AND REDEMPTION PRICE PER SHARE* | $ | 9.06 | $ | 8.02 | ||||||
* | Shares redeemed or exchanged within 120 days of purchase are charged a 2.00% redemption fee. |
See Notes to Financial Statements. | 16 |
CHOU AMERICA MUTUAL FUNDS STATEMENTS OF OPERATIONS SIX MONTHS ENDED JUNE 30, 2017 |
CHOU OPPORTUNITY FUND | CHOU INCOME FUND | ||||||||||
INVESTMENT INCOME | |||||||||||
Dividend income (Net of foreign withholding taxes of $6,840 and $0, respectively) | . | $ | 38,760 | $ | 84,759 | ||||||
Interest income | 2,274,942 | 188,297 | |||||||||
Securities lending | 995,902 | 3,748 | |||||||||
Total Investment Income | 3,309,604 | 276,804 | |||||||||
EXPENSES | |||||||||||
Investment adviser fees | 401,669 | 88,782 | |||||||||
Fund services fees | 45,042 | 43,025 | |||||||||
Custodian fees | 4,875 | 4,954 | |||||||||
Registration fees | 10,390 | 10,121 | |||||||||
Audit fees | 8,442 | 8,572 | |||||||||
Legal fees | 15,677 | 4,093 | |||||||||
Trustees' fees and expenses | 7,990 | 1,771 | |||||||||
Other expenses | 16,525 | 13,840 | |||||||||
Total Expenses | 510,610 | 175,158 | |||||||||
Fees waived and expenses reimbursed | (401,669 | ) | (68,620 | ) | |||||||
Net Expenses | 108,941 | 106,538 | |||||||||
NET INVESTMENT INCOME | 3,200,663 | 170,266 | |||||||||
NET REALIZED AND UNREALIZED GAIN | |||||||||||
Net realized gain on: | |||||||||||
Investments | 5,118,996 | 909,744 | |||||||||
Foreign currency transactions | - | 723 | |||||||||
Net realized gain | 5,118,996 | 910,467 | |||||||||
Net change in unrealized appreciation (depreciation) on: | |||||||||||
Investments | (7,364,161 | ) | (970,983 | ) | |||||||
Foreign currency translations | - | 11,478 | |||||||||
Written options | 8,772 | - | |||||||||
Net change in unrealized appreciation (depreciation) | (7,355,389 | ) | (959,505 | ) | |||||||
NET REALIZED AND UNREALIZED LOSS | (2,236,393 | ) | (49,038 | ) | |||||||
INCREASE IN NET ASSETS RESULTING FROM OPERATIONS | $ | 964,270 | $ | 121,228 | |||||||
See Notes to Financial Statements. | 17 |
CHOU AMERICA MUTUAL FUNDS STATEMENTS OF CHANGES IN NET ASSETS |
CHOU OPPORTUNITY FUND | CHOU INCOME FUND | ||||||||||||||||||
December 31, 2015 | Shares | Shares | |||||||||||||||||
NET ASSETS DECEMBER 31, 2015 | $ | 96,065,920 | $96,065,920 | $ | 15,252,823 | $15,252,823 | |||||||||||||
OPERATIONS | |||||||||||||||||||
Net investment income | 4,579,182 | 2,035,377 | |||||||||||||||||
Net realized loss | (782,865 | ) | (901,701 | ) | |||||||||||||||
Net change in unrealized appreciation (depreciation) | (9,322,201 | ) | 2,066,171 | ||||||||||||||||
Increase (Decrease) in Net Assets Resulting from Operations | (5,525,884 | ) | 3,199,847 | ||||||||||||||||
DISTRIBUTIONS TO SHAREHOLDERS FROM | |||||||||||||||||||
Net investment income | (5,261,532 | ) | (2,097,065 | ) | |||||||||||||||
Net realized gain | (46,847 | ) | - | ||||||||||||||||
Total Distributions to Shareholders | (5,308,379 | ) | (2,097,065 | ) | |||||||||||||||
CAPITAL SHARE TRANSACTIONS | |||||||||||||||||||
Sale of shares | 5,057,874 | 586,768 | 2,498,877 | 341,359 | |||||||||||||||
Reinvestment of distributions | 5,282,278 | 591,207 | 2,068,336 | 278,159 | |||||||||||||||
Redemption of shares | (12,165,674 | ) | (1,302,779 | ) | (3,037,871 | ) | (405,793 | ) | |||||||||||
Redemption fees | 991 | - | - | - | |||||||||||||||
Net contribution from affiliate (note 5) | 918,468 | - | - | - | |||||||||||||||
Increase (Decrease) in Net Assets from Capital Share Transactions | (906,063 | ) | (124,804 | ) | 1,529,342 | 213,725 | |||||||||||||
Increase (Decrease) in Net Assets | (11,740,326 | ) | 2,632,124 | ||||||||||||||||
NET ASSETS DECEMBER 31, 2016 (Including line (a)) | $ | 84,325,594 | $ | 17,884,947 | |||||||||||||||
OPERATIONS | |||||||||||||||||||
Net investment income | 3,200,663 | 170,266 | |||||||||||||||||
Net realized gain | 5,118,996 | 910,467 | |||||||||||||||||
Net change in unrealized appreciation (depreciation) | (7,355,389 | ) | (959,505 | ) | |||||||||||||||
Increase in Net Assets Resulting from Operations | 964,270 | 121,228 | |||||||||||||||||
DISTRIBUTIONS TO SHAREHOLDERS FROM | |||||||||||||||||||
Net investment income | (3,410,826 | ) | (116,553 | ) | |||||||||||||||
CAPITAL SHARE TRANSACTIONS | |||||||||||||||||||
Sale of shares | 2,142,659 | 229,534 | 107,183 | 13,249 | |||||||||||||||
Reinvestment of distributions | 3,392,800 | 376,559 | 115,045 | 14,363 | |||||||||||||||
Redemption of shares | (10,142,681 | ) | (1,093,214 | ) | (321,848 | ) | (40,044 | ) | |||||||||||
Redemption fees | 165 | - | 498 | - | |||||||||||||||
Decrease in Net Assets from Capital Share Transactions | (4,607,057 | ) | (487,121 | ) | (99,122 | ) | (12,432 | ) | |||||||||||
Decrease in Net Assets | (7,053,613 | ) | (94,447 | ) | |||||||||||||||
NET ASSETS JUNE 30, 2017 (Including line (b)) | $ | 77,271,981 | $ | 17,790,500 | |||||||||||||||
(a) | Undistributed (distributions in excess of) net investment income December 31, 2016 | $ | 236,080 | $ | (532,346 | ) | |||||||||||||
(b) | Undistributed (distributions in excess of) net investment income June 30, 2017 | $ | 25,917 | $ | (478,633 | ) |
See Notes to Financial Statements. | 18 |
CHOU OPPORTUNITY FUND FINANCIAL HIGHLIGHTS |
These financial highlights reflect selected data for a share outstanding throughout each period. | ||||||||||||||||||||||||
For the Six Months Ended | For the Year Ended December 31, | |||||||||||||||||||||||
June 30, 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||||||
NET ASSET VALUE, Beginning of Period | $ | 9.35 | $ | 10.51 | $ | 13.71 | $ | 13.52 | $ | 11.41 | $ | 10.00 | ||||||||||||
INVESTMENT OPERATIONS | ||||||||||||||||||||||||
Net investment income (loss) (a) | 0.37 | 0.51 | (0.14 | ) | (0.18 | ) | 0.05 | 0.32 | ||||||||||||||||
Net realized and unrealized gain (loss) | (0.24 | ) | (1.17 | ) | (2.91 | ) | 0.84 | 3.31 | 2.68 | |||||||||||||||
Total from Investment Operations | 0.13 | (0.66 | ) | (3.05 | ) | 0.66 | 3.36 | 3.00 | ||||||||||||||||
DISTRIBUTIONS TO SHAREHOLDERS FROM | ||||||||||||||||||||||||
Net investment income | (0.42 | ) | (0.59 | ) | — | — | (0.19 | ) | (0.40 | ) | ||||||||||||||
Net realized gain | — | (0.01 | ) | (0.15 | ) | (0.47 | ) | (1.09 | ) | (1.19 | ) | |||||||||||||
Total Distributions to Shareholders | (0.42 | ) | (0.60 | ) | (0.15 | ) | (0.47 | ) | (1.28 | ) | (1.59 | ) | ||||||||||||
REDEMPTION FEES (a) | — | (b) | — | (b) | — | (b) | — | (b) | 0.03 | — | (b) | |||||||||||||
NET CONTRIBUTION BY AFFILIATE (c) | — | 0.10 | — | — | — | — | ||||||||||||||||||
NET ASSET VALUE, End of Period | $ | 9.06 | $ | 9.35 | $ | 10.51 | $ | 13.71 | $ | 13.52 | $ | 11.41 | ||||||||||||
TOTAL RETURN | 1.38 | %(d) | (5.02 | )%(e) | (22.27 | )% | 4.88 | % | 29.82 | % | 30.81 | % | ||||||||||||
RATIOS/SUPPLEMENTARY DATA | ||||||||||||||||||||||||
Net Assets at End of Period (000's omitted) | $77,272 | $84,326 | $96,066 | $99,799 | $66,402 | $41,132 | ||||||||||||||||||
Ratios to Average Net Assets: | ||||||||||||||||||||||||
Net investment income (loss) | 7.97 | %(f) | 5.58 | % | (1.15 | )% | (1.31 | )% | 0.34 | % | 2.89 | % | ||||||||||||
Net expenses | 0.27 | %(f) | 0.30 | % | 1.24 | % | 1.38 | % | 1.48 | % | 1.48 | % | ||||||||||||
Gross expenses (g) | 1.27 | %(f) | 1.31 | % | 1.28 | % | 1.40 | % | 1.50 | % | 1.55 | % | ||||||||||||
PORTFOLIO TURNOVER RATE | 5 | %(d) | 18 | % | 4 | % | 29 | % | 56 | % | 17 | % | ||||||||||||
(a) | Calculated based on average shares outstanding during each period. | |||||||||||||||||||||||
(b) | Less than $0.01 per share. | |||||||||||||||||||||||
(c) | Calculated based on shares outstanding on February 18, 2016, the date of the capital contribution. See note 5. | |||||||||||||||||||||||
(d) | Not annualized. | |||||||||||||||||||||||
(e) | Calculation includes affiliate reimbursement and contribtuion of capital. Excluding the effect of the net reimbursements and contribution of capital from the Fund's ending net asset value per share, total return for the year ended December 31, 2016, would have been (6.04)%. | |||||||||||||||||||||||
(f) | Annualized. | |||||||||||||||||||||||
(g) | Reflects the expense ratio excluding any waivers and/or reimbursements. |
See Notes to Financial Statements. | 19 |
CHOU INCOME FUND FINANCIAL HIGHLIGHTS |
These financial highlights reflect selected data for a share outstanding throughout each period. | ||||||||||||||||||||||||
For the Six Months Ended | For the Year Ended December 31, | |||||||||||||||||||||||
June 30, 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||||||
NET ASSET VALUE, Beginning of Period | $ | 8.01 | $ | 7.56 | $ | 9.77 | $ | 11.04 | $ | 9.87 | $ | 8.74 | ||||||||||||
INVESTMENT OPERATIONS | ||||||||||||||||||||||||
Net investment income (a) | 0.08 | 0.96 | 0.90 | 0.51 | 0.94 | 1.58 | ||||||||||||||||||
Net realized and unrealized gain (loss) | (0.02 | ) | 0.49 | (2.01 | ) | (1.01 | ) | 1.28 | 1.27 | |||||||||||||||
Total from Investment Operations | 0.06 | 1.45 | (1.11 | ) | (0.50 | ) | 2.22 | 2.85 | ||||||||||||||||
DISTRIBUTIONS TO SHAREHOLDERS FROM | ||||||||||||||||||||||||
Net investment income | (0.05 | ) | (1.00 | ) | (0.95 | ) | (0.52 | ) | (1.07 | ) | (1.72 | ) | ||||||||||||
Net realized gain | — | — | (0.15 | ) | (0.25 | ) | — | — | (b) | |||||||||||||||
Total Distributions to Shareholders | (0.05 | ) | (1.00 | ) | (1.10 | ) | (0.77 | ) | (1.07 | ) | (1.72 | ) | ||||||||||||
REDEMPTION FEES (a) | — | (b) | — | — | (b) | — | (b) | 0.02 | — | |||||||||||||||
NET ASSET VALUE, End of Period | $ | 8.02 | $ | 8.01 | $ | 7.56 | $ | 9.77 | $ | 11.04 | $ | 9.87 | ||||||||||||
TOTAL RETURN | 0.79 | %(c) | 20.72 | % | (11.92 | )% | (4.83 | )% | 22.86 | % | 34.69 | % | ||||||||||||
RATIOS/SUPPLEMENTARY DATA | ||||||||||||||||||||||||
Net Assets at End of Period (000's omitted) | $17,791 | $17,885 | $15,253 | $17,526 | $14,737 | $6,728 | ||||||||||||||||||
Ratios to Average Net Assets: | ||||||||||||||||||||||||
Net investment income | 1.92 | %(d) | 12.91 | % | 9.94 | % | 4.48 | % | 8.39 | % | 16.25 | % | ||||||||||||
Net expenses | 1.20 | %(d) | 1.20 | % | 1.30 | % | 1.50 | % | 1.50 | % | 1.50 | % | ||||||||||||
Gross expenses (e) | 1.97 | %(d) | 2.10 | % | 2.36 | % | 2.11 | % | 3.41 | % | 4.09 | % | ||||||||||||
PORTFOLIO TURNOVER RATE | 3 | %(c) | 22 | % | 7 | % | 17 | % | 40 | % | 23 | % | ||||||||||||
(a) | Calculated based on average shares outstanding during each period. | |||||||||||||||||||||||
(b) | Less than $0.01 per share. | |||||||||||||||||||||||
(c) | Not annualized. | |||||||||||||||||||||||
(d) | Annualized. | |||||||||||||||||||||||
(e) | Reflects the expense ratio excluding any waivers and/or reimbursements. |
See Notes to Financial Statements. | 20 |
CHOU AMERICA MUTUAL FUNDS NOTES TO FINANCIAL STATEMENTS JUNE 30, 2017 |
Note 1. Organization
The Chou Opportunity Fund and Chou Income Fund (individually, a "Fund" and, collectively the "Funds") are non-diversified portfolios of Chou America Mutual Funds (the "Trust"). The Trust is a Delaware statutory trust that is registered as an open-end, management investment company under the Investment Company Act of 1940 (the "Act"), as amended. Under its Trust Instrument, the Trust is authorized to issue an unlimited number of each Fund's shares of beneficial interest without par value. Chou Opportunity Fund's investment objective is long-term growth of capital. Chou Income Fund's investment objective is to provide capital appreciation and income production, with capital preservation as a secondary consideration. The Funds commenced operations on July 1, 2010, with the sale of 50,000 shares of each Fund at $10 per share to Chou Associates Management Inc.
Note 2. Summary of Significant Accounting Policies
The Funds are investment companies and follow accounting and reporting guidance under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 946, "Financial Services-Investment Companies". These financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"), which require management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of increases and decreases in net assets from operations during the fiscal period. Actual amounts could differ from those estimates. The following summarizes the significant accounting policies of each Fund:
Security Valuation – Securities are valued at market prices using the last quoted trade or official closing price from the principal exchange where the security is traded, as provided by independent pricing services on each Fund business day. In the absence of a last trade, securities are valued at the mean of the last bid and ask price provided by the pricing service. Debt securities may be valued at prices supplied by a fund's pricing agent based on broker or dealer supplied valuations or matrix pricing, a method of valuing securities by reference to the value of other securities with similar characteristics such as rating, interest rate and maturity. Short-term investments that mature in 60 days or less may be valued at amortized cost.
Each Fund values its investments at fair value pursuant to procedures adopted by the Trust's Board of Trustees (the "Board") if (1) market quotations are not readily available or (2) the Adviser, as defined in Note 4, believes that the values available are unreliable. The Trust's Valuation Committee, as defined in each Fund's registration statement, performs certain functions as they relate to the administration and oversight of each Fund's valuation procedures. Under these procedures, the Valuation Committee convenes on a regular and ad hoc basis to review such investments and considers a number of factors, including valuation methodologies and significant unobservable inputs, when arriving at fair value.
The Valuation Committee may work with the Adviser to provide valuation inputs. In determining fair valuations, inputs may include market-based analytics that may consider related or comparable assets or liabilities, recent transactions, market multiples, book values and other relevant investment information. Adviser inputs may include an income-based approach in which the anticipated future cash flows of the investment are discounted in determining fair value. Discounts may also be applied based on the nature or duration of any restrictions on the disposition of the investments. The Valuation Committee performs regular reviews of valuation methodologies, key inputs and assumptions, disposition analysis and market activity.
Fair valuation is based on subjective factors and, as a result, the fair value price of an investment may differ from the security's market price and may not be the price at which the asset may be sold. Fair valuation could result in a different Net Asset Value ("NAV") than a NAV determined by using market quotes.
21 |
CHOU AMERICA MUTUAL FUNDS NOTES TO FINANCIAL STATEMENTS JUNE 30, 2017 |
GAAP has a three-tier fair value hierarchy. The basis of the tiers is dependent upon the various "inputs" used to determine the value of each Fund's investments. These inputs are summarized in the three broad levels listed below:
Level 1 — quoted prices in active markets for identical assets and liabilities
Level 2 — other significant observable inputs (including quoted prices of similar securities, interest rates, prepayment speeds, credit risk, etc.)
Level 3 — significant unobservable inputs (including each Fund's own assumptions in determining the fair value of investments)
The aggregate value by input level, as of June 30, 2017, for each Fund's investments is included at the end of each Fund's Schedule of Investments.
Security Transactions, Investment Income and Realized Gain and Loss – Investment transactions are accounted for on the trade date. Dividend income is recorded on the ex-dividend date. Foreign dividend income is recorded on the ex-dividend date or as soon as possible after determining the existence of a dividend declaration after exercising reasonable due diligence. Income and capital gains on some foreign securities may be subject to foreign withholding taxes, which are accrued as applicable. Interest income is recorded on an accrual basis. Premium is amortized and discount is accreted using the effective interest method. Identified cost of investments sold is used to determine the gain and loss for both financial statement and federal income tax purposes.
Foreign Currency Translations – Foreign currency amounts are translated into U.S. dollars as follows: (1) assets and liabilities at the rate of exchange at the end of the respective period; and (2) purchases and sales of securities and income and expenses at the rate of exchange prevailing on the dates of such transactions. The portion of the results of operations arising from changes in the exchange rates and the portion due to fluctuations arising from changes in the market prices of securities are not isolated. Such fluctuations are included with the net realized and unrealized gain or loss on investments.
Foreign Currency Transactions – Each Fund may enter into transactions to purchase or sell foreign currency contracts and options on foreign currency. Forward currency contracts are agreements to exchange one currency for another at a future date and at a specified price. A fund may use forward currency contracts to facilitate transactions in foreign securities, to manage a fund's foreign currency exposure and to protect the U.S. dollar value of its underlying portfolio securities against the effect of possible adverse movements in foreign exchange rates. These contracts are intrinsically valued daily based on forward rates, and a fund's net equity therein, representing unrealized gain or loss on the contracts as measured by the difference between the forward foreign exchange rates at the dates of entry into the contracts and the forward rates at the reporting date, is recorded as a component of NAV. These instruments involve market risk, credit risk, or both kinds of risks, in excess of the amount recognized in the Statement of Assets and Liabilities. Risks arise from the possible inability of counterparties to meet the terms of their contracts and from movement in currency and securities values and interest rates. Due to the risks associated with these transactions, a fund could incur losses up to the entire contract amount, which may exceed the net unrealized value included in its NAV.
Distributions to Shareholders – Distributions to shareholders of net investment income, if any, are declared and paid semi-annually. Distributions to shareholders of net capital gains, if any, are declared and paid at least annually. Distributions to shareholders are recorded on the ex-dividend date. Distributions are based on amounts calculated in accordance with applicable federal income tax regulations, which may differ from GAAP. These differences are due primarily to differing treatments of income and gain on various investment securities held by each Fund, timing differences and differing characterizations of distributions made by each Fund.
22 |
CHOU AMERICA MUTUAL FUNDS NOTES TO FINANCIAL STATEMENTS JUNE 30, 2017 |
Written Options – When a fund writes an option, an amount equal to the premium received by the fund is recorded as a liability and is subsequently adjusted to the current value of the option written. Premiums received from writing options that expire unexercised are treated by the fund on the expiration date as realized gain from written options. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security in determining whether the fund has realized a gain or loss. If a put option is exercised, the premium reduces the cost basis of the securities purchased by the fund. The fund, as writer of an option, bears the market risk of an unfavorable change in the price of the security underlying the written option. Written options are non-income producing securities.
Transactions in written options during the period ended June 30, 2017, were as follows:
Calls | |||||
Chou Opportunity Fund | Number of Contracts | Premiums | |||
Options Outstanding, December 31, 2016 | - | $ | - | ||
Options written | (8,618) | (1,074,952) | |||
Options terminated in closing transactions | - | - | |||
Options exercised | - | - | |||
Options expired | - | - | |||
Options Outstanding, June 30, 2017 | (8,618) | $ | (1,074,952) | ||
Federal Taxes – Each Fund intends to continue to qualify each year as a regulated investment company under Subchapter M of Chapter 1, Subtitle A, of the Internal Revenue Code of 1986, as amended ("Code"), and to distribute all of their taxable income to shareholders. In addition, by distributing in each calendar year substantially all of their net investment income and capital gains, if any, the Funds will not be subject to a federal excise tax. Therefore, no federal income or excise tax provision is required. Each Fund files a U.S. federal income and excise tax return as required. Each Fund's federal income tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed. As of June 30, 2017, there are no uncertain tax positions that would require financial statement recognition, de-recognition or disclosure.
Income and Expense Allocation – The Trust accounts separately for the assets, liabilities and operations of each of its investment portfolios. Expenses that are directly attributable to more than one investment portfolio are allocated among the respective investment portfolios in an equitable manner.
Redemption Fees – A shareholder who redeems or exchanges shares within 120 days of purchase will incur a redemption fee of 2.00% of the current NAV of shares redeemed or exchanged, subject to certain limitations. The fee is charged for the benefit of the remaining shareholders and will be paid to each Fund to help offset transaction costs. The fee is accounted for as an addition to paid-in capital. Each Fund reserves the right to modify the terms of or terminate the fee at any time. There are limited exceptions to the imposition of the redemption fee. Redemption fees incurred for the Funds, if any, are reflected on the Statements of Changes in Net Assets.
Commitments and Contingencies – In the normal course of business, each Fund enters into contracts that provide general indemnifications by each Fund to the counterparty to the contract. Each Fund's maximum exposure under these arrangements is dependent on future claims that may be made against each Fund and, therefore, cannot be estimated; however, based on experience, the risk of loss from such claims is considered remote.
23 |
CHOU AMERICA MUTUAL FUNDS NOTES TO FINANCIAL STATEMENTS JUNE 30, 2017 |
Note 3. Cash – Concentration in Uninsured Account
For cash management purposes, each Fund may concentrate cash with each Fund's custodian. This typically results in cash balances exceeding the Federal Deposit Insurance Corporation ("FDIC") insurance limits. As of June 30, 2017, Chou Opportunity Fund and Chou Income Fund had $9,485,422 and $3,714,175, respectively, at MUFG Union Bank, N.A. that exceeded the FDIC insurance limit.
Note 4. Fees and Expenses
Investment Adviser – Chou America Management Inc. (the "Adviser") is the investment adviser to each Fund. Pursuant to an investment advisory agreement, the Adviser receives an advisory fee, payable monthly, from each Fund at an annual rate of 1.00% of each Fund's average daily net assets.
Distribution – Rafferty Capital Markets, LLC serves as each Fund's distributor (the "Distributor"). The Trust has adopted a Rule 12b-1 plan under which the Funds may pay an annual fee of up to 0.25% of the average daily net assets of the Funds for distribution services and/or the servicing of shareholder accounts. The Board has not authorized the Funds to pay a Rule 12b-1 fee at this time. The Distributor is not affiliated with the Adviser or Atlantic Fund Administration, LLC (d/b/a Atlantic Fund Services) ("Atlantic") or their affiliates.
Other Service Providers – Atlantic provides fund accounting, fund administration, compliance and transfer agency services to each Fund. The fees related to these services are included in Fund services fees within the Statement of Operations. Atlantic also provides certain shareholder report production and EDGAR conversion and filing services. Pursuant to an Atlantic services agreement, each Fund pays Atlantic customary fees for its services. Atlantic provides a Principal Financial Officer, a Chief Compliance Officer, and an Anti-Money Laundering Officer to each Fund, as well as certain additional compliance support functions.
Trustees and Officers – The Trust pays each Independent Trustee an annual retainer fee of $8,240 for service to the Trust and the Audit and Compliance Committee Chairperson receives an additional retainer fee of $3,000. Each Trustee is also reimbursed for all reasonable out-of-pocket expenses incurred in connection with their duties as a Trustee, including travel and related expenses incurred in attending Board meetings. No officers of the Funds are compensated by the Funds, but officers are reimbursed for travel and related expenses incurred in attending Board meetings.
Note 5. Expense Reimbursements and Fees Waived
The Adviser has contractually agreed to waive a portion of its fee and/or reimburse certain expenses to limit total annual operating expenses to 1.20% of the average daily net assets of each Fund through at least May 1, 2018 (excluding other expenses, taxes, leverage interest, acquired fund fees and expenses, dividends or interest on short positions, other interest expenses, brokerage commissions, and extraordinary expenses such as litigation). The Adviser has voluntarily decided to waive its entire advisory fee on the Chou Opportunity Fund beginning on January 1, 2016. The Adviser can unilaterally decide to terminate this voluntary waiver at any time. For the period ended June 30, 2017, fees waived and expenses reimbursed were as follows:
Investment Adviser Fees Waived | |||
Chou Opportunity Fund | $ | 401,669 | |
Chou Income Fund | 68,620 |
24 |
CHOU AMERICA MUTUAL FUNDS NOTES TO FINANCIAL STATEMENTS JUNE 30, 2017 |
Note 6. Security Transactions
The cost of purchases and proceeds from sales of investment securities (including maturities), other than short-term investments during the period ended June 30, 2017, were as follows:
Purchases | Sales | |||||
Chou Opportunity Fund | $ | 8,285,960 | $ | 3,547,393 | ||
Chou Income Fund | 373,507 | 1,032,433 | ||||
Note 7. Summary of Derivative Activity
The volume of open derivative positions may vary on a daily basis as the Chou Opportunity Fund transacts derivative contracts in order to achieve the exposure desired by the Adviser. The notional value of activity for the period ended June 30, 2017 for any derivative type that was held during the period is as follows:
Written Options | $ | (1,074,952) |
The Chou Opportunity Fund's use of derivatives during the period ended June 30, 2017, was limited to written options.
Following is a summary of the effect of derivatives on the Chou Opportunity Fund's Statement of Assets and Liabilities as of June 30, 2017:
Location | Equity Contracts | ||||
Liability derivatives: | |||||
Call options written, at value | $ | (1,066,180 | ) |
Realized and unrealized gains and losses on derivatives contracts during the period ended June 30, 2017, by the Chou Opportunity Fund are recorded in the following locations on the Statement of Operations:
Location | Equity Contracts | ||||
Net change in unrealized appreciation (depreciation) on: | |||||
Written options | $ | 8,772 |
Asset (Liability) amounts shown in the table below represent amounts for derivative related investments at June 30, 2017. These amounts may be collateralized by cash or financial instruments.
Gross Asset (Liability) as Presented in the Statements of Assets and Liabilities | Financial Instruments (Received) Pledged** | Cash Collateral (Received) Pledged** | Net Amount | |||||||||||||
Liabilities: | ||||||||||||||||
Over-the-counter derivatives* | $ | (1,066,180 | ) | $ | 1,066,180 | $ | - | $ | - |
* | Over-the-counter derivatives may consist of options contracts. The amounts disclosed above represent the exposure to one or more counterparties. For further detail on individual derivative contracts and the corresponding unrealized appreciation (depreciation), see the Schedule of Investments. |
** | The actual financial instruments and cash collateral (received) pledged may be in excess of the amounts shown in the table. The table only reflects collateral amounts up to the amount of the financial instrument disclosed on the Statements of Assets and Liabilities. |
Note 8. Federal Income Tax
As of December 31, 2016, distributable earnings (accumulated loss) on a tax basis were as follows:
25 |
CHOU AMERICA MUTUAL FUNDS NOTES TO FINANCIAL STATEMENTS JUNE 30, 2017 |
Undistributed Ordinary Income | Capital and Other Losses | Unrealized Depreciation | Other Temporary Differences | Total |
Chou Opportunity Fund | $ | 236,080 | $ | (782,865 | ) | $ | (22,733,197 | ) | $ | - | $ | (23,279,982 | ) | |||||||
Chou Income Fund | - | (821,703 | ) | (4,724,299 | ) | (22,210 | ) | (5,568,212 | ) | |||||||||||
The difference between components of distributable earnings on a tax basis and the amounts reflected in the Statement of Assets and Liabilities are primarily due to wash sales and straddles for Chou Opportunity Fund and contingent payment debt instruments for Chou Income Fund.
As of December 31, 2016, the Chou Opportunity Fund and Chou Income Fund had $782,865 and $792,999, respectively, of available long-term capital loss carryforwards that have no expiration date.
For tax purposes, the prior late year ordinary loss was $28,704 (realized during the period November 1, 2016 through December 31, 2016) for Chou Income Fund. This loss was recognized for tax purposes on the first business day of the Fund's current fiscal year, January 1, 2017.
Note 9. Securities Lending Agreement
The Funds established a securities lending arrangement with The Bank of New York Mellon as securities lending agent in which the Funds lend portfolio securities to a broker in exchange for collateral consisting of cash or securities in an amount at least equal to the market value of the securities on loan. The following table presents the Chou Opportunity Fund's assets and liabilities net of related collateral held by the Chou Opportunity Fund at June 30, 2017:
Gross Amount of Assets and Liabilities in the Statements of Assets and Liabilities | Securities on Loan | Net Amount | ||||
Chou Opportunity Fund | $ | 526,513 | $ | (515,914) | $ | 10,599 |
Note 10. Recent Accounting Pronouncements
In October 2016, the U.S. Securities and Exchange Commission ("SEC") issued a new rule, Investment Company Reporting Modernization, which, among other provisions, amends Regulation S-X to require standardized enhanced disclosures, particularly related to derivatives, in investment company financial statements. The compliance date for the amendments to Regulation S-X is for reporting periods ending after August 1, 2017. Management has reviewed the requirements and believes the adoption of the amendments to Regulation S-X will not have a material impact on the Funds' financial statements and related disclosures.
Note 11. Subsequent Events
Subsequent events occurring after the date of this report through the date these financial statements were issued have been evaluated for potential impact, and each Fund has had no such events.
Proxy Voting Information
A description of the policies and procedures that each Fund uses to determine how to vote proxies relating to securities held in each Fund's portfolio is available, without charge and upon request, by calling (877) 682-6352 and on the U.S. Securities and Exchange Commission's website at www.sec.gov. Each Fund's proxy voting record for the most recent twelve-month period ended June 30 is available, without charge and upon request, by calling (877) 682-6352 and on the SEC's website at www.sec.gov.
Availability of Quarterly Portfolio Schedules
Each Fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. These filings are available, without charge and upon request on the SEC's website at www.sec.gov or may be reviewed and copied at the SEC's Public Reference Room in Washington, DC. Information on the operation of the Public Reference Room may be obtained by calling (800) SEC-0330.
Shareholder Expense Example
As a shareholder of the Funds, you incur two types of costs: (1) transaction costs, including redemption fees, and (2) ongoing costs, including management fees, distribution (12b-1) fees and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Funds, and to compare these costs with the ongoing costs of investing in other mutual funds.
The example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period from January 1, 2017, through June 30, 2017.
Actual Expenses – The first line of the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during the period.
Hypothetical Example for Comparison Purposes – The second line of the table below provides information about hypothetical account values and hypothetical expenses based on each Fund's actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not each Fund's actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as redemption fees. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
Beginning | Ending | Expenses | Annualized | ||||||||
Account Value | Account Value | Paid During | Expense | ||||||||
January 1, 2017 | June 30, 2017 | Period* | Ratio* | ||||||||
Chou Opportunity Fund | |||||||||||
Actual | $ | 1,000.00 | $ | 1,013.80 | $ | 1.35 | 0.27 | % | |||
Hypothetical (5% return before expenses) | $ | 1,000.00 | $ | 1,023.46 | $ | 1.35 | 0.27 | % | |||
Chou Income Fund | |||||||||||
Actual | $ | 1,000.00 | $ | 1,007.86 | $ | 5.97 | 1.20 | % | |||
Hypothetical (5% return before expenses) | $ | 1,000.00 | $ | 1,018.84 | $ | 6.01 | 1.20 | % | |||
* | Expenses are equal to each Fund's annualized expense ratio as indicated above multiplied by the average account value over the period, multiplied by the number of days in the most recent fiscal half-year (181) divided by 365 to reflect the half-year period. |
FOR MORE INFORMATION:
P.O. Box 588
Portland, ME 04112
(877) 682-6352
INVESTMENT ADVISER
Chou America Management Inc.
110 Sheppard Ave. East
Suite 301, Box 18
Toronto, Ontario, Canada M2N 6Y8
TRANSFER AGENT
Atlantic Fund Services
P.O. Box 588
Portland, ME 04112
www.atlanticfundservices.com
DISTRIBUTOR
Rafferty Capital Markets, LLC
1010 Franklin Avenue
Garden City, NY 11530
www.raffcap.com
This report is submitted for the general information of the shareholders of the Funds. It is not authorized for
distribution to prospective investors unless preceded or accompanied by an effective prospectus, which includes information regarding the Funds' risks, objectives, fees and expenses, experience of its management, and other information.
243-SAR-0617
ITEM 2. CODE OF ETHICS.
Not applicable.
ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.
Not applicable.
ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
Not applicable.
ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.
Not applicable
ITEM 6. INVESTMENTS.
(a) | Included as part of report to shareholders under Item 1. |
(b) | Not applicable. |
ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END
MANAGEMENT INVESTMENT COMPANIES.
Not applicable.
ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable.
ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.
Not applicable.
ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The Registrant does not accept nominees to the board of trustees from shareholders.
ITEM 11. CONTROLS AND PROCEDURES
(a) The Registrant's Principal Executive Officer and Principal Financial Officer have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the "Act")) are effective, based on their evaluation of the controls and procedures required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as of a date within 90 days of the filing date of this report.
(b) There were no changes in the Registrant's internal control over financial reporting (as defined in
Rule 30a-3(d) under the Act) that occurred during the second fiscal quarter of the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.
ITEM 12. EXHIBITS.
(a)(1) Not applicable.
(a)(2) Certifications pursuant to Rule 30a-2(a) of the Act, and Section 302 of the Sarbanes-Oxley Act of 2002. (Exhibits filed herewith)
(a)(3) Not applicable.
(b) Certifications pursuant to Rule 30a-2(b) of the Act, and Section 906 of the Sarbanes-Oxley Act of 2002. (Exhibit filed herewith)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant Chou America Mutual Funds
By: | /s/ Francis S.M. Chou |
Francis S.M. Chou, Principal Executive Officer | |
Date | August 25, 2017 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
By: | /s/ Francis S. M. Chou |
Francis S.M. Chou, Principal Executive Officer | |
Date | August 25, 2017 |
By: | /s/ Michael J. McKeen |
Michael J. McKeen, Principal Financial Officer | |
Date | August 25, 2017 |